These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12782539)

  • 1. VO2MAX, blood doping, and erythropoietin.
    Joyner MJ
    Br J Sports Med; 2003 Jun; 37(3):190-1. PubMed ID: 12782539
    [No Abstract]   [Full Text] [Related]  

  • 2. Super athletes or gene cheats?
    McCrory P
    Br J Sports Med; 2003 Jun; 37(3):192-3. PubMed ID: 12782540
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of alterations in total hemoglobin mass on VO 2max.
    Schmidt W; Prommer N
    Exerc Sport Sci Rev; 2010 Apr; 38(2):68-75. PubMed ID: 20335738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemoglobin, blood volume, cardiac function, and aerobic power.
    Gledhill N; Warburton D; Jamnik V
    Can J Appl Physiol; 1999 Feb; 24(1):54-65. PubMed ID: 9916181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for increasing oxygen and their potential use in doping: a review.
    Gaudard A; Varlet-Marie E; Bressolle F; Audran M
    Sports Med; 2003; 33(3):187-212. PubMed ID: 12656640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood boosting and sport.
    Ekblom BT
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):89-98. PubMed ID: 10932813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin in exercise adaptation.
    Burge CM
    Exerc Sport Sci Rev; 2010 Apr; 38(2):41. PubMed ID: 20335734
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of total haemoglobin mass: can it detect erythropoietin-induced blood manipulations?
    Lundby C; Robach P
    Eur J Appl Physiol; 2010 Jan; 108(1):197-200. PubMed ID: 19865825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American College of Sports Medicine position stand. The use of blood doping as an ergogenic aid.
    Sawka MN; Joyner MJ; Miles DS; Robertson RJ; Spriet LL; Young AJ
    Med Sci Sports Exerc; 1996 Jun; 28(6):i-viii. PubMed ID: 8926864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin receptor mutations and Olympic glory.
    Longmore GD
    Nat Genet; 1993 Jun; 4(2):108-10. PubMed ID: 8348144
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemoglobin and packed-cell volume in endurance athletes prior to rhEPO.
    Kujala UM; Peltonen JE; Elovainio RO
    Int J Sports Med; 2000 Apr; 21(3):228-30. PubMed ID: 10834359
    [No Abstract]   [Full Text] [Related]  

  • 12. Altitude Training and Recombinant Human Erythropoietin: Considerations for Doping Detection.
    Sutehall S; Muniz-Pardos B; Lima G; Wang G; Malinsky FR; Bosch A; Zelenkova I; Tanisawa K; Pigozzi F; Borrione P; Pitsiladis Y
    Curr Sports Med Rep; 2019 Apr; 18(4):97-104. PubMed ID: 30969231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances].
    Scheen AJ
    Rev Med Liege; 1998 Aug; 53(8):499-502. PubMed ID: 9810213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living high-training low: effect on erythropoiesis and maximal aerobic performance in elite Nordic skiers.
    Robach P; Schmitt L; Brugniaux JV; Nicolet G; Duvallet A; Fouillot JP; Moutereau S; Lasne F; Pialoux V; Olsen NV; Richalet JP
    Eur J Appl Physiol; 2006 Aug; 97(6):695-705. PubMed ID: 16786355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-linear relationships between central cardiovascular variables and VO2 during incremental cycling exercise in endurance-trained individuals.
    Vella CA; Robergs RA
    J Sports Med Phys Fitness; 2005 Dec; 45(4):452-9. PubMed ID: 16446675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial oxygen carriers--the new doping threat in endurance sport?
    Schumacher YO; Schmid A; Dinkelmann S; Berg A; Northoff H
    Int J Sports Med; 2001 Nov; 22(8):566-71. PubMed ID: 11719891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". New strategies in the fight against doping are necessary.
    Schumacher YO; Pottgiesser T
    J Appl Physiol (1985); 2008 Dec; 105(6):1994; author reply 1997-8. PubMed ID: 19140259
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant erythropoietin to improve athletic performance.
    Adamson JW; Vapnek D
    N Engl J Med; 1991 Mar; 324(10):698-9. PubMed ID: 1994258
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the physiological response to simulated altitude exposure and r-HuEpo administration.
    Ashenden MJ; Hahn AG; Martin DT; Logan P; Parisotto R; Gore CJ
    J Sports Sci; 2001 Nov; 19(11):831-7. PubMed ID: 11695504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose exogenous erythropoietin elicits an ergogenic effect in standardbred horses.
    McKeever KH; Agans JM; Geiser S; Lorimer PJ; Maylin GA
    Equine Vet J Suppl; 2006 Aug; (36):233-8. PubMed ID: 17402424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.